Literature DB >> 11309249

Involvement of PACAP receptor in primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord.

Y Sakashita1, T Kurihara, D Uchida, I Tatsuno, T Yamamoto.   

Abstract

The role of PACAP receptor in nociceptive transmission was investigated in vitro using maxadilan, a PACAP receptor selective agonist and max.d.4, a PACAP receptor selective antagonist. Potentials, from a ventral root (L3 - L5) of an isolated spinal cord preparation or a spinal cord - saphenous nerve - skin preparation from 0 - 3-day-old rats, were recorded extracellularly. In the isolated spinal cord preparation, single shock stimulation of a dorsal root at C-fibre strength induced a slow depolarizing response lasting about 30 s (slow ventral root potential; slow VRP) in the ipsilateral ventral root of the same segment. Bath-application of max. d.4 (0.01 - 3 microM) inhibited the slow VRP in a concentration-dependent manner. In the spinal cord - saphenous nerve - skin preparation, application of capsaicin (0.1 microM) to the skin evoked a depolarization of the ventral root. This response was also depressed by max.d.4 (1 microM). Application of maxadilan evoked a long-lasting depolarization in a concentration-dependent manner in the spinal cord preparation. In the presence of max.d.4 (0.3 microM), the concentration response curve of maxadilan was shifted to the right. Reverse transcription-polymerase chain reaction (RT - PCR) experiments demonstrated the existence of PACAP receptor and VPAC(2) receptor in the neonatal rat spinal cord and [(125)I]-PACAP27 binding was displaced almost completely by maxadilan and max.d.4, but not by vasoactive intestinal peptide (VIP). These data indicate that PACAP receptor is dominantly distributed in the neonatal rat spinal cord. The present study suggests that PACAP receptor may play an excitatory role in nociceptive transmission in the neonatal rat spinal cord.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309249      PMCID: PMC1572720          DOI: 10.1038/sj.bjp.0703980

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist.

Authors:  O Moro; K Wakita; M Ohnuma; S Denda; E A Lerner; M Tajima
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

2.  The isolated spinal cord-skin preparation of the newborn rat and effects of some algogenic and analgesic substances.

Authors:  M Yanagisawa; R Hosoki; M Otsuka
Journal:  Eur J Pharmacol       Date:  1992-09-22       Impact factor: 4.432

3.  The excitatory and inhibitory modulation of primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord exerted by nitric oxide.

Authors:  T Kurihara; K Yoshioka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Pituitary adenylate cyclase activating polypeptide expression in sensory neurons.

Authors:  H Mulder; R Uddman; K Moller; Y Z Zhang; E Ekblad; J Alumets; F Sundler
Journal:  Neuroscience       Date:  1994-11       Impact factor: 3.590

Review 5.  Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems.

Authors:  A Arimura
Journal:  Jpn J Physiol       Date:  1998-10

6.  Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.

Authors:  S R Rawlings; I Piuz; W Schlegel; J Bockaert; L Journot
Journal:  Endocrinology       Date:  1995-05       Impact factor: 4.736

7.  Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord-tail preparation of the newborn rat.

Authors:  M Otsuka; M Yanagisawa
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

8.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.

Authors:  T Ishihara; R Shigemoto; K Mori; K Takahashi; S Nagata
Journal:  Neuron       Date:  1992-04       Impact factor: 17.173

9.  Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3.

Authors:  R Propato-Mussafiri; S M Kanse; M A Ghatei; S R Bloom
Journal:  J Endocrinol       Date:  1992-01       Impact factor: 4.286

10.  Pituitary adenylate cyclase activating peptide produces a marked and long-lasting depression of a C-fibre-evoked flexion reflex.

Authors:  Y Z Zhang; B Sjölund; K Moller; R Håkanson; F Sundler
Journal:  Neuroscience       Date:  1993-12       Impact factor: 3.590

View more
  3 in total

1.  Effects of intrathecal administration of pituitary adenylate cyclase activating polypeptide on lower urinary tract functions in rats with intact or transected spinal cords.

Authors:  Mitsuharu Yoshiyama; William C de Groat
Journal:  Exp Neurol       Date:  2008-03-07       Impact factor: 5.330

2.  Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test.

Authors:  Tatsuo Yamamoto; Natsuko Nozaki-Taguchi; Tanemichi Chiba
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

3.  Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.

Authors:  Masafumi Yokai; Takashi Kurihara; Atsuro Miyata
Journal:  Mol Pain       Date:  2016-05-12       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.